
Rejuvenation Technologies Inc.
Rejuvenation Technologies Inc. is a YC Summer 2018 (S18) company. Based in Mountain View, CA, USA. Team of 2.
About Rejuvenation Technologies Inc.
Summary
Rejuvenation Technologies Inc. develops mRNA-based therapies that lengthen telomeres, the protective DNA sequences that shorten as cells divide and age. Delivering TERT mRNA can reverse more than a decade of telomere shortening within days, targeting diseases driven by critically short telomeres, including pulmonary fibrosis, liver disease, and bone marrow failure. The company is translating this approach from the lab into clinical trials, replacing the absence of any approved treatment that addresses cellular aging at the chromosomal level.
From the Y Combinator listing
We extend telomeres to extend the human health span
Delivery of TERT mRNA extends telomeres sufficiently in a few days to reverse over a decade of telomere shortening during normal aging. We are advancing TERT mRNA-based therapies to the clinic.
Facts
- Healthcare / Healthcare -> Therapeutics
- Mountain View, CA, USA
- 2
- Active
- Early
Founders (2)
- Glenn Markov
- John Ramunas
Score every batch against your own thesis
GPAgent's sourcing agent reads every company in a batch, scores each one against your fund's thesis in a private workspace, and lines up the founders worth meeting before Demo Day. You decide who to contact. Your scores, notes, and pipeline never appear on these pages.
How Accelerator intelligence works